newsfilter
← Latest News
Business Wire·

DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2024 Financial Results

Conference Call and Webcast March 18 at 8:00 AM Eastern Time / 7:00 AM Central Time Preeclampsia Phase 2 Trial Preliminary Topline Safety and Efficacy Data from Part 1A of the Study Expected in the Second Quarter of